Company or ticker...

PTC Therapeutics

PTC develops medicines for rare genetic and neuromuscular diseases.

Ticker

M. Cap

PS

PE

YTD

10MA

20MA

50MA

200MA

PTCT

7.0B

8.5

n/a

10.58%

Key Facts

M. Cap

PS

PE

YTD

7.0B

8.5

n/a

10.58%

10MA

20MA

50MA

200MA

$PTCT